Bromperidol is a typical antipsychotic medication belonging to the butyrophenone class. It acts primarily by blocking dopamine D₂ receptors in the brain, helping to reduce symptoms such as agitation, hallucinations, and severe behavioral disturbances. Bromperidol has been used in the treatment of acute psychosis, schizophrenia, and severe agitation, particularly in inpatient settings. Due to the risk of extrapyramidal side effects and other neurological reactions, its use requires careful dosing and close medical supervision, and it is less commonly used today compared with newer antipsychotic agents.